RA
HOLX icon

Royce & Associates’s Hologic HOLX Stock Holding History

Royce & Associates’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,700
Closed -$466K – 1256
2017
Q3 		$466K Sell
12,700
-7,300
-37% -$295K ﹤0.01% 1029
2017
Q2 		$908K Buy
+20,000
New +$883K 0.01% 988

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royce & Associates's HOLX Position: Q4 2017 in Review

Royce & Associates sold out of Hologic (HOLX) in Q4 2017, closing a stake of 12,700 shares — an estimated $466K sold.

Royce & Associates first reported a position in HOLX in Q2 2017 and held it in 2 quarters. The position peaked at $908K in Q2 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Royce & Associates reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Royce & Associates sold 12,700 Hologic shares in Q4 2017, an estimated $466K.
  • Royce & Associates first reported a position in Hologic in Q2 2017 and held it in 2 quarters.
  • Royce & Associates's Hologic position peaked at $908K in Q2 2017.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Royce & Associates's 13F filing for Q4 2017, filed 9 Feb 2018.